The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Srebp-controlled glucose metabolism is essential for NK cell functional responses
Open accessAbstract
Activated natural killer (NK) cells engage in a robust metabolic response that is required for normal effector function. Using genetic, pharmacological and metabolic analyses, we demonstrated an essential role for Srebp transcription factors in cytokine-induced metabolic reprogramming of NK cells that was independent of their conventional role in the control of lipid synthesis. Srebp was required for elevated glycolysis and oxidative phosphorylation and promoted a distinct metabolic pathway configuration in which glucose was metabolized to cytosolic citrate via the citrate-malate shuttle. Preventing the activation of Srebp or direct inhibition of the citrate-malate shuttle inhibited production of interferon-γ and NK cell cytotoxicity. Thus, Srebp controls glucose metabolism in NK cells, and this Srebp-dependent regulation is critical for NK cell effector function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, it was demonstrated that the citrate–malate shuttle performs functions beyond that of an electron shuttle and, in fact, supports continuous citrate regeneration and TCA cycle intermediate homeostasis (119, 121).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [119]
Citations
Cites
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
Cheng, S.-C., Quintin, J., Cramer, R. A., Shepardson, K. M., Saeed, S., Kumar, V., Giamarellos-Bourboulis, E. J., Martens, J. H. A., Rao, N. A., Aghajanirefah, A., et al. (2014) · Science · doi:10.1126/science.1250684 · Cited by 2,224
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
Huang, S. C., Everts, B., Ivanova, Y., O’Sullivan, D., Nascimento, M., Smith, A. M., Beatty, W. L., Love-Gregory, L. D., Lam, W. Y., O’Neill, C. M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2956 · Cited by 1,256
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,081
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G. B., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R. P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells
Berod, L., Friedrich, C., Nandan, A., Freitag, J., Hagemann, S., Harmrolfs, K., Sandouk, A., Hesse, C., Castro, C. N., Bähre, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3704 · Cited by 927
Cited by
Sorted by citations
Metabolism of immune cells in cancer
Leone, R. D., & Powell, J. D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0273-y · Cited by 877
Natural killer cells in cancer biology and therapy
Wu, S.-Y., Fu, T., Jiang, Y.-Z., & Shao, Z.-M. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01238-x · Cited by 863
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0301-4 · Cited by 880
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 793
Redox regulation of the immune response
Morris, G., Gevezova, M., Sarafian, V. S., & Maes, M. H. J. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00902-0 · Cited by 628
Williams, N. C., & O'Neill, L. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00141 · Cited by 599
Regulation and function of the mammalian tricarboxylic acid cycle
Arnold, P. K., & Finley, L. W. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102838 · Cited by 535
“Citrate efflux from mitochondria has since been found to be a major process in some cancers, for example, cholesterol-rich rat hepatomas and and immune cells (38, 119, 120).”
BackgroundNK Cell Metabolism and Tumor Microenvironment
Terrén, I., Orrantia, A., Vitallé, J., Zenarruzabeitia, O., & Borrego, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02278 · Cited by 523
Lipids in the tumor microenvironment: From cancer progression to treatment
Corn, K. C., Windham, M. A., & Rafat, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101055 · Cited by 486
Immunometabolism and natural killer cell responses
O’Brien, K., & Finlay, D. K. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0139-2 · Cited by 452
Self-citationInfluence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Melaiu, O., Lucarini, V., Cifaldi, L., & Fruci, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03038 · Cited by 424
Lipogenesis inhibitors: therapeutic opportunities and challenges
Batchuluun, B., Pinkosky, S. L., & Steinberg, G. R. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00367-2 · Cited by 419
Loftus, R. M., Aßmann, N., Kedia-Mehta, N., O’Brien, K., Garcia, A., Gillespie, C. S., Hukelmann, J. L., Oefner, P. J., Lamond, A. I., Gardiner, C. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04719-2 · Cited by 403
Self-citationCong, J., Wang, X., Zheng, X., Wang, D., Fu, B., Sun, R., Tian, Z., & Wei, H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.021 · Cited by 387
Harmon, C., Robinson, M. W., Hand, F., Almuaili, D., Mentor, K., Houlihan, D. D., Hoti, E., Lynch, L., Geoghegan, J., & O’Farrelly, C. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0481 · Cited by 384
Self-citationHuang, Z., Blum, R. H., Bernareggi, D., Ask, E. H., Wu, Z., Hoel, H. J., Meng, Z., Wu, C., Guan, K., Malmberg, K., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.05.008 · Cited by 360
Metabolic Codependencies in the Tumor Microenvironment
Dey, P., Kimmelman, A. C., & DePinho, R. A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1211 · Cited by 349
Finley, L. W. S. (2023) · Cell · doi:10.1016/j.cell.2023.01.038 · Cited by 343
Pyroptosis, metabolism, and tumor immune microenvironment
Du, T., Gao, J., Li, P., Wang, Y., Qi, Q., Liu, X., Li, J., Wang, C., & Du, L. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.492 · Cited by 335
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance
Zheng, X., Qian, Y., Fu, B., Jiao, D., Jiang, Y., Chen, P., Shen, Y., Zhang, H., Sun, R., Tian, Z., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0511-1 · Cited by 316
Metabolic interventions in the immune response to cancer
O’Sullivan, D., Sanin, D. E., Pearce, E. J., & Pearce, E. L. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0140-9 · Cited by 320
Crosstalk between glucose metabolism, lactate production and immune response modulation
Ye, L., Jiang, Y., & Zhang, M. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.11.001 · Cited by 326
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy
Riera-Domingo, C., Audigé, A., Granja, S., Cheng, W.-C., Ho, P.-C., Baltazar, F., Stockmann, C., & Mazzone, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2019 · Cited by 310
Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment
Poznanski, S. M., Singh, K., Ritchie, T. M., Aguiar, J. A., Fan, I. Y., Portillo, A. L., Rojas, E. A. P., Vahedi, F., El‐Sayes, A., Xing, S., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.023 · Cited by 309
A non-canonical tricarboxylic acid cycle underlies cellular identity
Arnold, P. K., Jackson, B. T., Paras, K. I., Brunner, J. S., Hart, M. L., Newsom, O. J., Alibeckoff, S. P., Endress, J., Drill, E., Sullivan, L. B., et al. (2022) · Nature · doi:10.1038/s41586-022-04475-w · Cited by 304
Competition for nutrients and its role in controlling immune responses
Kedia-Mehta, N., & Finlay, D. K. (2019) · Nature Communications · doi:10.1038/s41467-019-10015-4 · Cited by 287
Self-citationExtracellular vesicles: mediators of intercellular communication in tissue injury and disease
Sánchez, G. B., Bunn, K. E., Pua, H. H., & Rafat, M. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00787-y · Cited by 297
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Liu, S., Zhang, X., Wang, W., Li, X., Sun, X., Zhao, Y., Wang, Q., Li, Y., Hu, F., & Ren, H. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02165-x · Cited by 300
Wen, Y., Xiong, X., Zaytseva, Y. Y., Napier, D. L., Vallee, E., Li, A. T., Wang, C., Weiss, H. L., Evers, B. M., & Gao, T. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0330-6 · Cited by 225
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Xiao, Y.-L., Gong, Y., Qi, Y.-J., Shao, Z., & Jiang, Y.-Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01771-x · Cited by 218
Metabolism in tumor microenvironment: Implications for cancer immunotherapy
Shi, R., Tang, Y., & Miao, H. (2020) · MedComm · doi:10.1002/mco2.6 · Cited by 210
Natural Killer Cells: From Innate to Adaptive Features
Mujal, A. M., Delconte, R. B., & Sun, J. C.-Y. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-074948 · Cited by 199
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Guerra, L., Bonetti, L., & Brenner, D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107848 · Cited by 194
Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response
Cassim, S., & Pouysségur, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010157 · Cited by 192
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Wang, W., Liu, Y., He, Z., Li, L., Liu, S., Jiang, M., Zhao, B., Deng, M., Wang, W., Ge, X., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01815-9 · Cited by 197
Long-term reprogramming of the innate immune system
Domínguez‐Andrés, J., & Netea, M. G. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-104r · Cited by 182
Kobayashi, T., Lam, P. Y., Jiang, H., Bednarska, K., Gloury, R., Murigneux, V., Tay, J., Jacquelot, N., Li, R. Q., Tuong, Z. K., et al. (2020) · Blood · doi:10.1182/blood.2020005602 · Cited by 175
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 165
Kusnadi, A., Park, S. H., Yuan, R., Pannellini, T., Giannopoulou, E., Oliver, D., Lu, T., Park-Min, K.-H., & Ivashkiv, L. B. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.005 · Cited by 157
NK Cell Dysfunction and Checkpoint Immunotherapy
Bi, J., & Tian, Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01999 · Cited by 152
The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity
Kornberg, M. D. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1486 · Cited by 151
What Defines NK Cell Functional Fate: Phenotype or Metabolism?
Poznanski, S. M., & Ashkar, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01414 · Cited by 146
NK cell exhaustion in the tumor microenvironment
Hao, J., Yang, H., Xiong, H., & Luo, K. Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303605 · Cited by 131
Immune cell metabolism and metabolic reprogramming
Hu, C., Xuan, Y., Zhang, X., Liu, Y., Yang, S., & Yang, K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07474-2 · Cited by 132
Siska, P. J., Singer, K., Evert, K., Renner, K., & Kreutz, M. P. (2020) · Immunological Reviews · doi:10.1111/imr.12846 · Cited by 125
Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
Terrén, I., Orrantia, A., Astarloa-Pando, G., Amarilla-Irusta, A., Zenarruzabeitia, O., & Borrego, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.884648 · Cited by 123
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms
Regis, S., Dondero, A., Caliendo, F., Bottino, C., & Castriconi, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00311 · Cited by 118
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
Lian, X., Yang, K., Li, R., Li, M., Zuo, J., Zheng, B., Wang, W., Wang, P., & Zhou, S. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01486-5 · Cited by 120
Diet, lipids, and antitumor immunity
Prendeville, H., & Lynch, L. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00781-x · Cited by 126
Self-citationCholesterol metabolism: a new molecular switch to control inflammation
Cardoso, D., & Perucha, E. (2021) · Clinical Science · doi:10.1042/cs20201394 · Cited by 116
Huang, K., Han, Y., Chen, Y., Shen, H., Zeng, S., & Cai, C. (2025) · Molecular Cancer · doi:10.1186/s12943-024-02205-6 · Cited by 121
Dysregulation of Natural Killer Cells in Obesity
O'Shea, D. B., & Hogan, A. E. (2019) · Cancers · doi:10.3390/cancers11040573 · Cited by 115
Cancer-associated adipocytes as immunomodulators in cancer
Wu, Q., Li, B., Li, J., Sun, S., Yuan, J., & Sun, S. (2021) · Biomarker Research · doi:10.1186/s40364-020-00257-6 · Cited by 105
Metabolic Routes in Inflammation: The Citrate Pathway and its Potential as Therapeutic Target
Infantino, V., Pierri, C. L., & Iacobazzi, V. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180510124558 · Cited by 96
Molecular definition of group 1 innate lymphoid cells in the mouse uterus
Filipovic, I., Chiossone, L., Vacca, P., Hamilton, R. S., Ingegnere, T., Doisne, J., Hawkes, D., Mingari, M. C., Sharkey, A., Moretta, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06918-3 · Cited by 95
Peng, M., Yang, D., Hou, Y., Liu, S., Zhao, M., Qin, Y., Chen, R., Teng, Y., & Liu, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1475-7 · Cited by 96
RetractedOvercoming tumor resistance mechanisms in CAR-NK cell therapy
Valeri, A., García-Ortiz, A., Castellano, E., Córdoba, L., Maroto-Martín, E., Encinas, J., Leivas, A., Río, P., & Martínez‐López, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953849 · Cited by 96
Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors
Pahl, J. H. W., Cerwenka, A., & Ni, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02796 · Cited by 99
Gardiner, C. M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-260r · Cited by 96
Self-citationAkt and STAT5 mediate naïve human CD4+ T-cell early metabolic response to TCR stimulation
Jones, N., Vincent, E. E., Cronin, J., Panetti, S., Chambers, M., Holm, S. R., Owens, S. E., Francis, N., Finlay, D. K., & Thornton, C. A. (2019) · Nature Communications · doi:10.1038/s41467-019-10023-4 · Cited by 88
Self-citationImmunometabolism in cancer at a glance
Singer, K., Cheng, W.-C., Kreutz, M. P., Ho, P., & Siska, P. J. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034272 · Cited by 87
Metabolic requirements of NK cells during the acute response against retroviral infection
Littwitz-Salomon, E., Moreira, D., Frost, J. N., Choi, C., Liou, K. T., Ahern, D. K., O’Shaughnessy, S., Wagner, B., Biron, C. A., Drakesmith, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25715-z · Cited by 86
Self-citationNAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
Guo, X., Tan, S., Wang, T., Sun, R., Li, S., Tian, P., Li, M., Wang, Y., Zhang, Y., Yan, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32658 · Cited by 81
Miao, L., Lu, C., Zhang, B., Li, H., Zhao, X., Chen, H., Liu, Y., & Cui, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05033-w · Cited by 89
Schafer, J. R., Salzillo, T. C., Chakravarti, N., Kararoudi, M. N., Trikha, P., Foltz, J. A., Wang, R., Li, S., & Lee, D. A. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.047 · Cited by 81
Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function
Poznanski, S. M., Barra, N. G., Ashkar, A. A., & Schertzer, J. D. (2018) · Inflammation Research · doi:10.1007/s00011-018-1174-3 · Cited by 78
Mosaoa, R., Kasprzyk-Pawelec, A., Fernandez, H. R., & Avantaggiati, M. L. (2021) · Biomolecules · doi:10.3390/biom11020141 · Cited by 80
Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
Chambers, A. M., Lupo, K. B., & Matosevic, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02517 · Cited by 79
Exploring the Role of ATP-Citrate Lyase in the Immune System
Dominguez, M., Brüne, B., & Namgaladze, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632526 · Cited by 79
SREBP signaling is essential for effective B cell responses
Luo, W., Adamska, J. Z., Li, C., Verma, R., Liu, Q., Hagan, T., Wimmers, F., Gupta, S., Feng, Y., Jiang, W., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01376-y · Cited by 74
Driving immunity: all roads lead to metabolism
Pearce, E. J., & Pearce, E. L. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.139 · Cited by 77
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 93
The Immune Consequences of Lactate in the Tumor Microenvironment
Harmon, C., O’Farrelly, C., & Robinson, M. W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_7 · Cited by 73
O’Brien, A., Loftus, R. M., Pisarska, M. M., Tobin, L. M., Bergin, R., Wood, N., Foley, C., Mat, A., Tinley, F. C., Bannan, C., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801600 · Cited by 71
Self-citationNanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Zhou, Y., Yuan, J. T., Xu, K., Li, S., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c11260 · Cited by 73
Luci, C., Vieira, E., Perchet, T., Gual, P., & Golub, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01192 · Cited by 73
Metabolism of Natural Killer Cells and Other Innate Lymphoid Cells
Cong, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01989 · Cited by 73
Solute carrier transporters: emerging central players in tumour immunotherapy
Chen, R., & Chen, L. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.08.002 · Cited by 69
Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
Martínez-Chantar, M. L., Delgado, T. C., & Beraza, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640869 · Cited by 67
The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
Domagała, J., Lachota, M., Kłopotowska, M., Graczyk‐Jarzynka, A., Domagała, A., Zhylko, A., Soroczyńska, K., & Winiarska, M. (2020) · Cancers · doi:10.3390/cancers12123542 · Cited by 69
Coronavirus Infection and Cholesterol Metabolism
Dai, J., Wang, H., Liao, Y., Tan, L., Sun, Y., Song, C., Liu, W., Qiu, X., & Ding, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.791267 · Cited by 68
Santarsiero, A., Convertini, P., Todisco, S., Pierri, C. L., Grassi, A., Williams, N. C., Iacobazzi, D., Stefano, G. D., O'Neill, L. A. J., & Infantino, V. (2021) · Cells · doi:10.3390/cells10112962 · Cited by 68
Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection
Heieis, G. A., Patente, T. A., Almeida, L., Vrieling, F., Tak, T., Perona‐Wright, G., Maizels, R. M., Stienstra, R., & Everts, B. (2023) · Nature Communications · doi:10.1038/s41467-023-41353-z · Cited by 67
Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy
Choi, C., & Finlay, D. K. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02377-8 · Cited by 66
Self-citationRole of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
Liu, Z., Le, Y., Chen, H., Zhu, J., & Lu, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.748573 · Cited by 66
Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
Myers, J. A., Schirm, D. K., Bendzick, L. E., Hopps, R., Selleck, C., Hinderlie, P., Felices, M., & Miller, J. S. (2022) · JCI Insight · doi:10.1172/jci.insight.150079 · Cited by 63
Wang, D., Sun, Z., Zhu, X., Zheng, X., Zhou, Y., Lu, Y., Yan, P., Wang, H., Liu, H., Jin, J., et al. (2022) · Blood · doi:10.1182/blood.2022015474 · Cited by 67
Mikelez-Alonso, I., Magadán, S., González‐Fernández, Á., & Borrego, F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113860 · Cited by 63
NK Cell Metabolism and TGFβ – Implications for Immunotherapy
Slattery, K., & Gardiner, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02915 · Cited by 63
Self-citationMetabolic regulation of NK cell function: implications for immunotherapy
Sohn, H., & Cooper, M. A. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000020 · Cited by 57
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
Chowdhury, S., Kar, A., Bhowmik, D., Gautam, A., Basak, D., Sarkar, I., Ghosh, P., Sarkar, D., Deka, A., Chakraborty, P., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4052 · Cited by 58
Metabolism of Innate Immune Cells in Cancer
Talty, R., & Olino, K. L. (2021) · Cancers · doi:10.3390/cancers13040904 · Cited by 55
Extracellular citrate and metabolic adaptations of cancer cells
Parkinson, E. K., Adamski, J., Zahn, G., Gaumann, A. K. A., Flores‐Borja, F., Ziegler, C. M., & Mycielska, M. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10007-1 · Cited by 50
Fatty Acid Metabolism and Cancer Immunotherapy
Luo, Y., Wang, H., Liu, B., & Wei, J. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01223-1 · Cited by 53
Metabolism in the progression and metastasis of brain tumors
Tyagi, A., Wu, S.-Y., & Watabe, K. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215713 · Cited by 59
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 56
Metabolite releasing polymers control dendritic cell function by modulating their energy metabolism
Mangal, J. L., Inamdar, S., Yang, Y., Dutta, S., Wankhede, M., Shi, X., Gu, H., Green, M., Rege, K., Curtis, M., et al. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00790k · Cited by 50
Taylor, H. E., Calantone, N., Lichon, D., Hudson, H., Clerc, I., Campbell, E. M., & D’Aquila, R. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107810 · Cited by 48
Jiang, L., Fei, H., Jin, X., Liu, X., Yang, C., Li, C., Chen, J., Yang, A., Zhu, J., Wang, H., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63390 · Cited by 49
Natural killer cells and type 1 innate lymphoid cells in cancer
Lopes, N., Vivier, É., & Narni-Mancinelli, É. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2022.101709 · Cited by 51
Metadata
- Authors
- Assmann, N., O'Brien, K. L., Donnelly, R. P., Dyck, L., Zaiatz-Bittencourt, V., Loftus, R. M., Heinrich, P., Oefner, P. J., Lynch, L., Gardiner, C. M., Dettmer, K., & Finlay, D. K.
- Affiliations
- Trinity College Dublin (IE)
- University of Regensburg (DE)
- Corresponding author
- Finlay, David K
- ORCID
- Venue
- Nature Immunology
- Published
- 2017-09-18
- Volume
- 18
- Issue
- 11
- Pages
- 1197-1206
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2755907400
- Cited by
- 375
- References
- 57
- Citations by year
- 2026: 35 · 2025: 54 · 2024: 37 · 2023: 44 · 2022: 53 · 2021: 57 · 2020: 45 · 2019: 25 · 2018: 21 · 2017: 4
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
- zenodo.org
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- natural killer cells, SREBP, glucose metabolism, metabolic reprogramming, glycolysis, oxidative phosphorylation, interferon-gamma, NK cell cytotoxicity, cytokine activation, antitumor immunity, viral infection
- MeSH terms
- Animals, Flow Cytometry, Glucose, Glycolysis, Humans, Killer Cells, Natural, Lipids, Oxidative Phosphorylation, Immunoblotting, T-Lymphocyte Subsets, Cytokines, Cell Proliferation, Sterol Regulatory Element Binding Protein 1, Sterol Regulatory Element Binding Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review